P1530: PERITRANFUSIONAL C1-INHIBITOR IN PATIENTS WITH SEVERE COMPLEMENT-MEDIATED AUTOIMMUNE HEMOLYTIC ANEMIA: AN OPEN LABEL PHASE 2 TRIAL. (23rd June 2022) - de Boer, E. C. W.; Jalink, M.; Delvasto-Nuñes, L.; Meulenbroek, E. M.; Baas, I.; Janssen, S. R.; Dijkman, E. E.; Gelderman, K. A.; Wouters, D.; Engel, M. D.; de Haas, M.; Kersten, M.-J.; et al.